Mexican Peso Nears 18.75 As Iran Risks And AI Selloff Hit Sentiment
October 22, 2026
The Mexican Peso weakened toward 18.75 as Middle East tensions and AI-related debt concerns fueled US Dollar demand.
Mentions: UUP
Uber Stock At $68.17 Draws Big Options Bets: Is The Low In?
Strong free cash flow and high analyst price targets suggest the ride-sharing giant remains significantly undervalued.
Bitcoin Down 23%, Oil Up 79%, But JPM Still Favors Bitcoin
Bitcoin fell 23% this year as oil surged, but JPMorgan ranks the asset first for returns over the next decade.
GLP-1 Hits Apparel: 13% Of Americans Have Used One, Now What?
GLP-1 drugs are reshaping the apparel market as plus-size demand cools and wardrobe replacements accelerate.
CoreWeave Default Odds Top 60% As Its Bond Yield Hits 15%
Investors increasingly worry that massive capex requirements are outstripping cash flows, creating systemic risks for the Nasdaq.
CoreWeave Debt Tops $51 Billion: Is Big Trouble Brewing For AI?
Rising credit risks at CoreWeave and hot inflation data are fueling a sharp selloff in AI and semiconductor stocks.
LATEST ARTICLES
The Geopolitics Super Cycle And What It Means For Gold
October 22, 2026
A structural geopolitics super cycle is driving a tenfold rise in tariffs, ending the era of frictionless trade.
Mentions: GLD
Market Coiling
October 22, 2026
Precious metals are coiling for a major move as gold and silver remain range-bound despite soaring deficits and refining shifts toward China.
Rates Spark: US And France Like Ships Passing In The Night At 5%
October 22, 2026
10-year French government bonds are now yielding above 5%, whereas the US 10-year Treasury has dipped below 5%.
The AI Boom Has An Interest Payment Due
October 22, 2026
Plunging CoreWeave bonds signal a shift in AI debt as investors demand higher yields.
Stocks And Precious Metals Charts - Wild Swings
October 22, 2026
Gold and silver prices plummeted ahead of Comex options expiration, while oil remains volatile amid geopolitical tensions.
Dow Heads North As Tech Goes South
October 22, 2026
The Dow and equal-weighted S&P 500 are marking new breakouts as investors rotate away from overbought Tech.
All Data Now Points To A Recession In Home Prices
October 22, 2026
A housing market recession is imminent as data indicates home prices will grind lower through next year.
A New Sector Rotation?
October 22, 2026
Weakening semiconductors and gains in retail signal an active sector rotation as algorithmic volatility rises.
Nasdaq Sinks 694 Points As AI Spending Fears Resurface
October 22, 2026
The Nasdaq tumbled nearly 700 points as Meta Platforms and Nvidia led a tech sell-off amid renewed AI spending fears.
Why Moderna Stock Plunged Despite Positive Cancer Vaccine Trial Results?
October 22, 2026
Moderna shares cratered as leaked cancer vaccine data triggered a sell-the-news reaction despite meeting efficacy goals.
In This Article: MRNA
If I Had Only Invested Then: Investor’s Time Machine
October 22, 2026
Early investments in Microsoft and Nvidia have outperformed other tech giants, with $10,000 stakes now worth over $50 million.
Three Key Challenges Facing Tesla-SpaceX Merger
October 22, 2026
Tesla faces major hurdles in a potential SpaceX merger: complex valuations, SEC scrutiny, and China-related security risks.
Traders Switch To Defense
October 22, 2026
Investors are rotating into defensive sectors and bonds as Meta Platforms sparks concerns over AI spending.
EDITOR'S CHOICE
Strong free cash flow and high analyst price targets suggest the ride-sharing giant remains significantly undervalued.
Bitcoin fell 23% this year as oil surged, but JPMorgan ranks the asset first for returns over the next decade.
GLP-1 drugs are reshaping the apparel market as plus-size demand cools and wardrobe replacements accelerate.
IN THE SPOTLIGHT
Silver (XAGUSD) faces downward pressure as technical patterns suggest the correction could extend toward the $45–50...
Opera is projected to gain 17.4% next year, driven by steady share price growth and a 4.55% dividend yield.
Micron dominates with 104% revenue growth, yet high accruals suggest a looming cyclical peak.
Two announcements on the same day reveal how INmune Bio is preparing for a potential transition from clinical-stage...
Accelerating US inflation signaled a hawkish Fed, sparking an S&P 500 sell-off. The Swiss franc surged as a safe-haven...